PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1604554
PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1604554
The global microparticles market is expected to grow at a CAGR of 10.25%, reaching a market size of US$2.325 billion in 2030 from US$1.427 billion in 2025.
Microparticles are solid particles composed of synthetic or natural polymers and typically are in the order of micrometers in size (1-1000 μm). It can be prepared by dispersing, entrapping, encapsulating, or suspending the active drug within the polymer matrix. This method of encapsulation of drug and polymer leads to a more appropriate variation of the type of microparticles depending upon the drug to be encapsulated and the choice of the polymer.
Moreover, microspheres are microparticles with a wide spherical surface-to-volume ratio and homogeneously entrapping the drug in the matrix. They can also be categorized into solid and hollow types. Since the improved targeted efficiency, magnetic microspheres have also been explored for targeted drug delivery, particularly magnetic-targeted chemotherapy.
Microparticles market drivers
Moreover, these microparticles protect vulnerable molecules like proteins and mRNA from degradation for effective delivery to intended sites. Of the various biodegradable polymers most used within the framework of microparticle systems, PLGA is safe and biocompatible. It is significantly finding notable importance in pulmonary drug delivery: Formulations that are inhalable help deliver drugs efficiently in disease treatment related to the respiratory system and reduce systemic exposure with higher precision.
Microparticles market geographical outlook
The Asia Pacific microparticles market is anticipated to expand at a rapid rate, driven by rapid urbanization and demand for advanced technologies across diversified industries. The pharmaceutical industries in China and India are some of the prime growth drivers, as investment in drug delivery systems and biotechnology research is on the rise. For instance, the total market size of the Indian pharma industry is expected to reach US$130 billion by 2030 and US$450 billion by 2047. Moreover, automobile manufacturing within the domestic market alone is projected to be well over 35 million automobiles in 2025 within China.
Similarly, according to the OICA data, automotive production has enhanced by 30% in India in 2021. The favorable government policies include the newly initiated PLI schemes, which include auto and auto components. The recently established innovative chemistry cell for auto manufacturing, the FAME-II Policy until 2024, and a newly launched Rs 76,000 crore PLI scheme on semiconductor manufacturing are boosting the microparticle market growth in the country.
Additionally, the automotive and electronics industries in Japan, South Korea, and China are increasingly incorporating microparticles into materials to improve performance, fuel efficiency, and durability. The region's focus on sustainability and environmental solutions also fuels the demand for microparticles in water treatment, pollution control, and green technologies. Data released by the American Institute of Architects' (AIA) Shanghai office indicate that China is expected to construct ten cities similar to New York by 2025. Nonetheless, favorable government policies, growing R&D capabilities, and a large consumer base further contribute to the strong growth potential of the microparticle market in Asia Pacific.
Reasons for buying this report:-
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence